Scribd Logo
Upload

Welcome to Scribd!

  • U.S. Army Patent For Weaponized Mycoplasma

    Uploaded by

    Adam F.
    5K views81 pages
    Mycoplasma fermentans incognitus, variations, and mutations thereof, is a debilitating fungal parasitic infection like AIDS that turns off the immune system and reactivates latent virus and other opportunistic infections. After it was weaponized in biological warfare programs, criminal factions of the U.S. Military allowed it to get sold to Iraq and other foreign countries. They also allowed it to be tested illegally on U.S. prisoners and mental health facilities. In the process of trying to keep it contained as a weapon, it has escaped into the natural world and is reeking havoc. You may wonder why all this extra toxic junk is added to vaccines, because they're desperately trying to kill the mycoplasma, but its hardly effective. It is now carried by ticks, mosquitoes and plenty of other insects, birds, mammals, etc. Can you imagine the legal nightmare if people started to demand answers?

    Original Title

    U.S. Army Patent for Weaponized Mycoplasma

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Mycoplasma fermentans incognitus, variations, and mutations thereof, is a debilitating fungal parasitic infection like AIDS that turns off the immune system and reactivates latent virus and other opportunistic infections. After it was weaponized in biological warfare programs, criminal factions of the U.S. Military allowed it to get sold to Iraq and other foreign countries. They also allowed it to be tested illegally on U.S. prisoners and mental health facilities. In the process of trying to keep it contained as a weapon, it has escaped into the natural world and is reeking havoc. You may wonder why all this extra toxic junk is added to vaccines, because they're desperately trying to kill the mycoplasma, but its hardly effective. It is now carried by ticks, mosquitoes and plenty of other insects, birds, mammals, etc. Can you imagine the legal nightmare if people started to demand answers?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    5K views81 pages

    U.S. Army Patent For Weaponized Mycoplasma

    Uploaded by

    Adam F.
    Mycoplasma fermentans incognitus, variations, and mutations thereof, is a debilitating fungal parasitic infection like AIDS that turns off the immune system and reactivates latent virus and other opportunistic infections. After it was weaponized in biological warfare programs, criminal factions of the U.S. Military allowed it to get sold to Iraq and other foreign countries. They also allowed it to be tested illegally on U.S. prisoners and mental health facilities. In the process of trying to keep it contained as a weapon, it has escaped into the natural world and is reeking havoc. You may wonder why all this extra toxic junk is added to vaccines, because they're desperately trying to kill the mycoplasma, but its hardly effective. It is now carried by ticks, mosquitoes and plenty of other insects, birds, mammals, etc. Can you imagine the legal nightmare if people started to demand answers?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 81

    IlllllllllllllIllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll

    US005242820A
    United States Patent [191 [11] Patent Number: 5,242,820
    Lo [45] Date of Patent: Sep. 7, 1993

    [54] PATHOGENIC MYCOPLASMA Lo et al (1989) Fatal Infection of Silvered Leaf Mon


    keys . . .' Am. T Trop Med Hyg 40(4):399409.
    [75] Inventor: Shyh-Ching Lo, Potomac, Md. Lo et a1 (1989) Virus-dike Infectious Agent . . . Am J
    [73] Assignee: American Registry of Pathology, Trop Med Hyg 4l(5):586600.
    Washington, DC. Marquart et a1 (Feb. 1985) Abstract Only Eur J Clin
    Microbiol 4(1):73-74.
    [21] Appl. No.: 710,361 Hu et a] (1990) Gene 93:67-72.
    [22] Filed: Jun. 6, 1991 Primary ExaminerChristine M. Nucker
    Assistant Examiner-D. R. Preston
    Related [35. Application Data Attorney, Agent, or Finn-Venable, Baetjer, Howard &
    Civiletti.
    [63] Continuationin-part of Ser. No. 265,920, Nov. 2, 1988,
    abandoned, which is a continuation-in-part of Ser. No. [57] ABSTRACT
    875,535, Jun. 18, 1986, abandoned. The invention relates to a novel pathogenic myco
    [51] Int. Cl.5 ....................... .. CIZN 5/00; C12N 5/02; plasma isolated from patients with Acquired Immune
    C12N l/OO; C12Q 1/70 De?ciency Syndrome (AIDS) and its use in detecting
    [52] US. Cl. ................................... .. 435/2401; 435/5; antibodies in sera of AIDS patients, patients with
    435/872 AIDS-related complex (ARC) or patients dying of dis
    [58] Field of Search ............... .. 435/870, 5, 872, 240.2 eases and symptoms resembling AIDS diseases. The
    invention further relates to speci?c DNA sequences,
    [56] References Cited antibodies against the pathogenic mycoplasma, and
    PUBLICATIONS their use in detecting DNA or antigens of the patho
    genic mycoplasma or other genetically and serologi
    Marquart et a] (1985) Mycoplasrna-Like Structures . . . cally closely related mycoplasmas in infected tissue of
    Eur J Clin Microbiol 4(l):73-74. patients with AIDS or ARC or patients dying of symp
    Lo et al (1989) A Novel Virus-like Infectious Agent . . . toms resembling AIDS diseases. The invention still
    Am J Trop Med Hyg 40(2):213226. - further relates to a variety of different forms of vaccine
    Lo et al (1989) Identi?cation of M Incognitus . . . Am. J. against mycoplasma infection in humans and/or ani
    Trop-Med. I-Iyg 4l(5):60l-6l6. mals.
    Lo et al (1989) Association of the Virus-like Agent . . .
    Am J Trop Med Hyg 4l(3):364-376. 2 Claims, 39 Drawing Sheets
    US. Patent Sep. 7, 1993 Sheet 1 of 39 5,242,820

    FIG. 1A FIG. 18
    US. Patent Sep.7,1993 Sheet 2 of 39 5,242,820

    FlG. 1C

    FIG. 1D
    US. Patent Sep. 7, 1993 Sheet 3 of 39 5,242,820

    FIG. 2A FIG. 28
    25456T8S1QUL2 l 2 34 5 6 7B

    O c a O 0

    Ah
    0 s s u

    Ht:
    (3 s i 0

    Cb

    zm-nrwca"l DO

    Eb
    .Fb
    b
    O

    O
    0 0 0 0

    O
    0

    O
    0

    O
    o

    O
    US. Patent Sep. 7, 1993 Sheet 4 of 59 5,242,820

    FIG.3A FIG.3B
    12_s4ss7a 1 23456.78

    "'1 '1 II:


    :

    FIG.I3C FIG. 3D
    12345678 1 2345678

    II:
    -._C
    I.-, I::

    F|G._3E
    12345678

    I:
    US. Patent Sep. 7, 1993 Sheet 5 of 39 5,242,820

    FIG. 4A FIG. 48
    US. Patent Sep.7,1993 Sheet 7 of 39 5,242,820

    II
    I
    I
    II

    \I

    %
    6%mm
    wwwm
    1us1
    %
    ?g _
    _
    _
    _
    _
    _
    _
    _
    _

    l.I '
    \79
    7.2
    U.S. Patent Sep. 7, 1993 Sheet 9 of 39 5,242,820
    US. Patent Sep.7,1993 Sheet 10 of 39 5,242,820
    US. Patent Sep. 7, 1993 Sheet 11 of 39 5,242,820

    Am.9- g
    0
    ..m
    .n

    0 .UEm
    .n
    m

    m
    . .n
    _m

    .dm.
    iH n
    4H 4 H
    US. Patent Sep.7,1993 Sheet 12 of 39 5,242,820

    FIG. 10A

    FIG. 10B FIG. 100


    US. Patent Sep.7,1993 Sheet 13 M39 5,242,820
    US. Patent Sep. 7, 1993 Sheet 14 of .39 5,242,820

    <NP0.26Em8.wm.om
    US. Patent Sep.7,1993 Sheet 15 of 39 5,242,820

    FIG; 13

    FIG. 14
    US. Patent sep. 7, 1993 sheet 16 0539 5,242,820

    A FIG.- 15A FIG. 158


    l 2 3 4 I 2' 3 4
    K? 55;; v

    8.6 1
    I
    II

    '

    FIG. 16
    ~123456789IO
    Kb
    US. Patent Sep. 7, 1993 Sheet 17 of-39 5,242,820

    2750': #cPM
    2500f *g/mL

    O 5 I0 I5 2O 25
    FRACTION NUMBER
    US. Patent Sep. 7, 1993 Sheet 18 339 5,242,820

    CONTROL
    |- | 2
    I3-24
    F '6' 17B VLIA INFECTED
    |-|2
    13-24

    CONTROL
    I - I 2

    FIG. 18A VLIA'3-24


    INFECTED
    I- I 2
    I 3-24

    CONTROL

    FIG. 18B "5354


    VLIA INFECTED
    US. Patent Sep. 7, 1993 Sheet 19 of 39 5,242,820

    I II
    I23456 I25456 I23456 H3456

    FIG. 19A FIG. 198


    I II I II
    |23456 I23456, I23456 I23456

    -
    .- .

    FIG. 19C
    -

    FIG. 19D

    I II I II
    I23456 |25456 I25456 I25456

    s" v' F
    FIG. 19E :I
    I
    FIG. 19F
    I II I II
    I23456 I23456 H5456 I23456
    Q

    FIG. 19G II" 0 I '

    FIG. 19H

    You might also like